2-year mouse and rat: no significant increase in neoplasms
“Two-year carcinogenicity studies conducted in mice and rats showed no significant increase in neoplasms in males or females in either study; the CDER Exec CAC concurred with this conclusion.”
Rat EFD: reduced fetal weight and retarded ossification at maternally toxic 10 mg/kg/day (19x unbound AUC)
“In the embryo-fetal toxicity study in rats, finerenone resulted in reduced placental weights and signs of fetal toxicity, including reduced fetal weights and retarded ossification at the maternal toxic dose of 10 mg/kg/day, corresponding to an AUC unbound of 19 times that in humans.”
No adverse CNS, respiratory, hemodynamic/ECG or hERG effects
“Finerenone showed no adverse effects on CNS parameters and respiratory functions (rat), on hemodynamic/ECG parameters (dog), and on cardiac repolarization in vitro (hERG K+ current).”
Not genotoxic overall: Ames negative; in vitro chromosome aberration positive without (not with) metabolic activation; rat micronucleus and comet negative